Your browser doesn't support javascript.
loading
Evaluation of Critical Quality Attributes of a Pentavalent (A, C, Y, W, X) Meningococcal Conjugate Vaccine for Global Use.
Bolgiano, Barbara; Moran, Eilís; Beresford, Nicola J; Gao, Fang; Care, Rory; Desai, Trusha; Nordgren, Ida Karin; Rudd, Timothy R; Feavers, Ian M; Bore, Prashant; Patni, Sushil; Gavade, Vinay; Mallya, Asha; Kale, Sameer; Sharma, Pankaj; Goel, Sunil K; Gairola, Sunil; Hattarki, Suhas; Avalaskar, Nikhil; Sarma, Annamraju D; LaForce, Marc; Ravenscroft, Neil; Khandke, Lakshmi; Alderson, Mark R; Dhere, Rajeev M; Pisal, Sambhaji S.
Afiliação
  • Bolgiano B; National Institute for Biological Standards and Control, South Mimms, Potters Bar EN6 3QG, UK.
  • Moran E; National Institute for Biological Standards and Control, South Mimms, Potters Bar EN6 3QG, UK.
  • Beresford NJ; National Institute for Biological Standards and Control, South Mimms, Potters Bar EN6 3QG, UK.
  • Gao F; National Institute for Biological Standards and Control, South Mimms, Potters Bar EN6 3QG, UK.
  • Care R; National Institute for Biological Standards and Control, South Mimms, Potters Bar EN6 3QG, UK.
  • Desai T; National Institute for Biological Standards and Control, South Mimms, Potters Bar EN6 3QG, UK.
  • Nordgren IK; National Institute for Biological Standards and Control, South Mimms, Potters Bar EN6 3QG, UK.
  • Rudd TR; National Institute for Biological Standards and Control, South Mimms, Potters Bar EN6 3QG, UK.
  • Feavers IM; National Institute for Biological Standards and Control, South Mimms, Potters Bar EN6 3QG, UK.
  • Bore P; Serum Institute of India Pvt. Ltd., Hadapsar, Pune 411028, India.
  • Patni S; Serum Institute of India Pvt. Ltd., Hadapsar, Pune 411028, India.
  • Gavade V; Serum Institute of India Pvt. Ltd., Hadapsar, Pune 411028, India.
  • Mallya A; Serum Institute of India Pvt. Ltd., Hadapsar, Pune 411028, India.
  • Kale S; Serum Institute of India Pvt. Ltd., Hadapsar, Pune 411028, India.
  • Sharma P; Serum Institute of India Pvt. Ltd., Hadapsar, Pune 411028, India.
  • Goel SK; Serum Institute of India Pvt. Ltd., Hadapsar, Pune 411028, India.
  • Gairola S; Serum Institute of India Pvt. Ltd., Hadapsar, Pune 411028, India.
  • Hattarki S; Serum Institute of India Pvt. Ltd., Hadapsar, Pune 411028, India.
  • Avalaskar N; Serum Institute of India Pvt. Ltd., Hadapsar, Pune 411028, India.
  • Sarma AD; Serum Institute of India Pvt. Ltd., Hadapsar, Pune 411028, India.
  • LaForce M; Serum Institute of India Pvt. Ltd., Hadapsar, Pune 411028, India.
  • Ravenscroft N; Department of Chemistry, University of Cape Town, Rondebosch, Cape Town 7701, South Africa.
  • Khandke L; Center for Vaccine Innovation and Access, PATH, Seattle, WA 98121, USA.
  • Alderson MR; Center for Vaccine Innovation and Access, PATH, Seattle, WA 98121, USA.
  • Dhere RM; Serum Institute of India Pvt. Ltd., Hadapsar, Pune 411028, India.
  • Pisal SS; Serum Institute of India Pvt. Ltd., Hadapsar, Pune 411028, India.
Pathogens ; 10(8)2021 Jul 23.
Article em En | MEDLINE | ID: mdl-34451392
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pathogens Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pathogens Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido